The model was next used to predict the effects of the siRNA-mediated inhibition of PCSK9 synthesis, upon administration of inclisiran, in hypercholesterolemia subjects on statin treatment (Fig. 1C). Here, PCSK9 is linked to Hypercholesterolemia.